American Cancer Society
Study identifies potential 'safe period' for hormone replacement use
Published in Clinical Oncology Week, February 16th, 2009
A new study makes important new findings on the role of hormone use on the risk of breast cancer, confirming that the use of estrogen plus progesterone increases the risk of both ductal and lobular breast cancer far more than estrogen-only; suggesting a two-year "safe" period for the use of estrogen and progesterone; and finding that the increased risk for ductal cancers observed in long-term past users of hormone replacement therapy drops off substantially two years after hormone use is stopped. The study appears in CANCER, a peer-reviewed journal of the American Cancer Society.
Previous studies have shown that hormone replacement therapy after menopause increases the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- American Association for Cancer Research
Beach vacations may increase future skin cancer risk in children - Fox Chase Cancer Center
Regular physical activity linked to better quality of life in early-stage lung cancer survivors - JAMA and Archives Journals
Cardiac imaging method may expose patients to high radiation dose - Lifespan
Research to provide information of long-term effects of childhood cancer treatment to parents - New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
New insights into growth factor's role in brain development - Swiss Institute of Bioinoformatics
Stroma genomic signature predicts resistance to anthracyclin-based chemotherapy in breast cancer - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
